Docetaxel‐based chemotherapy combined with dexamethasone 1 mg daily oral administration for castration‐resistant prostate cancer: Long‐term outcomes-Reference-Cited by-同舟云学术

Docetaxel‐based chemotherapy combined with dexamethasone 1 mg daily oral administration for castration‐resistant prostate cancer: Long‐term outcomes

Published:2019-05-05 Issue:8 Volume:26 Page:797-803
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int. J. Urol.

Author:

Tanaka Nobumichi¹,Nishimura Kazuo²,Okajima Eijiro³,Ina Kenji⁴,Ogawa Osamu⁵,Nagata Hirohiko⁶,Akakura Koichiro⁷,Fujimoto Kiyohide¹,Gotoh Momokazu⁸,Teramukai Satoshi⁹,Hirao Yoshihiko¹¹⁰

Affiliation:

1. Department of Urology Nara Medical University Kashihara Japan

2. Department of Urology Osaka International Cancer Institute Osaka Japan

3. Department of Urology Nara City Hospital Nara Japan

4. Department of Chemotherapy Nagoya Memorial Hospital Nagoya Japan

5. Department of Urology Kyoto University Kyoto Japan

6. Department of Urology Keio University Tokyo Japan

7. Department of Urology JCHO Tokyo Shinjuku Medical Center Tokyo Japan

8. Department of Urology Nagoya University Nagoya Japan

9. Department of Biostatistics Kyoto Prefectural University of Medicine Kyoto Japan

10. Department of Urology Osaka Gyoumeikan Hospital Osaka Japan

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.14009

Reference16 articles.

1. Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

2. Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer

3. Abiraterone and Increased Survival in Metastatic Prostate Cancer

4. Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

5. Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase 1 Study to Evaluate the Safety of Reducing the Prophylactic Dose of Dexamethasone around Docetaxel Infusion in Patients with Prostate and Breast Cancer;Cancers;2023-03-09

2. Advantages and drawbacks of dexamethasone in glioblastoma multiforme;Critical Reviews in Oncology/Hematology;2022-04

3. Targeting therapy for prostate cancer by pharmaceutical and clinical pharmaceutical strategies;Journal of Controlled Release;2021-05

4. Appropriate Number of Docetaxel Cycles in Castration-Resistant Prostate Cancer Patients Considering Peripheral Neuropathy and Oncological Control;Chemotherapy;2021-01-22

5. The Effect of Treatment Sequence on Overall Survival for Men With Metastatic Castration-resistant Prostate Cancer: A Multicenter Retrospective Study;Clinical Genitourinary Cancer;2020-04